The All Ordinaries Index (ASX: XAO) had a fairly disappointing day of trading on Wednesday. At market close, the All Ords had slipped by 0.06% to 7,226.1 points. But that doesn't mean all All Ords shares are following suit.
So let's check out three ASX All Ords shares that had had a cracker of a day today, each rising over 10% at one point.
3 All Ords shares that leapt over 10%
Webjet Limited (ASX: WEB)
ASX travel share Webjet is our first All Ords company to take stock of today. Webjet shares finished up a healthy 8.02% at $5.52 each. But the travel company rose as high as $5.70 after lunchtime, a gain worth more than 11% at the time.
This seems to be a response to the trading update the company put out this morning alongside its annual general meeting. This informed investors that Webjet has had a great and profitable start to FY23.
The company expects cash flow to exceed $100 million over the first half of the financial year. Investors have obviously liked what they heard there.
Tyro Payments Ltd (ASX: TYR)
Tyro Payments is another ASX All Ords share that had a day to remember this Wednesday. At the close, the Tyro share price finished 11.93% higher at $1.22 after climbing as high as $1.23 this morning.
In this case, it seems investors are continuing to flood into Tyro shares following the company's full-year earnings for FY22 that were delivered on Monday.
Tyro announced a 34% rise in payments statutory gross profit to $147.7 million. But it also reported a statutory loss after tax of $29.6 million, slightly down from the $29.8 million loss of FY21. Even so, investors seem to approve, with Tyro shares now up almost 20% this week.
Clinuvel Pharmaceuticals Limited (ASX: CUV)
Finally today we have All Ords pharma company Clinuvel. Clinuvel shares gained an impressive 16.19% to $20.17 at market close today. Earlier, the Clinuvel share price reached as high as $20.43.
This company also delivered its FY22 numbers yesterday. But the reaction at the time was far more muted than the gains we saw today. Perhaps the investor webinar that was released to investors this morning got some more blood flowing.
This highlighted Clinuvel's 37% rise in revenues, the 33% increase in net profit before tax to $34.2 million and the 60% spike in the annual dividend to 4 cents per share. Investors evidently liked what the company had to say.
